Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoprevention of Lung Carcinogenesis Using Green Tea: Phase IIb Randomized, Double-Blinded, Placebo Controlled Trial of Green Tea and Polyphenon E in Former Smokers With Chronic Obstructive Lung Disease (COPD)

NCT00363805 is registered in ClinicalTrials.gov with Sherry Chow as lead sponsor.

NCT NCT00363805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoprevention of Lung Carcinogenesis Using Green Tea: Phase IIb Randomized, Double-Blinded, Placebo Controlled Trial of Green Tea and Polyphenon E in Former Smokers With Chronic Obstructive Lung Disease (COPD)
Lead sponsor
Sherry Chow
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
Not reported
Enrollment
178 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer prevention